Literature DB >> 24194305

Lipid-stimulated somatostatin secretion in rainbow trout,Oncorhynchus mykiss.

N M Carneiro1, C D Eilertson, M A Sheridan.   

Abstract

Previous work has shown that somatostatins (SS) affect teleost lipid metabolism indirectly by inhibition of insulin (INS) and directly by stimulation of hepatic lipolysis. In the present study, rainbow trout (Oncorhynchus mykiss) were used to characterize further the lipid-SS relationship by evaluating how lipid, contributes to SS secretion bothin vivo andin vitro. In vivo hyperlipidemia was induced for up to 3 h by short-term (2 min) infusion of a triacylglycerol (TG)-rich lipid emulsion (20% Intralipid(®)). Plasma total lipid concentration increased 118 and 155% over control levels 1 h and 3 h, respectively, after infusion; much of this increase was due to elevated plasma fatty acids (FA), which increased 39 and 520%, respectively, over the same time-frame. The hyperlipidemic pattern was attended by a significant increase in the plasma concentration of SS. The specific effects of fatty acids were evaluated on isolated Brockmann bodies. Palmitic acid and oleic acid stimulated SS release 378 and 82%, respectively, over baseline levels. These results indicate that lipids, and in particular fatty acids, modulate SS secretion in rainbow trout.

Entities:  

Year:  1996        PMID: 24194305     DOI: 10.1007/BF01875588

Source DB:  PubMed          Journal:  Fish Physiol Biochem        ISSN: 0920-1742            Impact factor:   2.794


  14 in total

1.  Effects of nutritional state on in vivo lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch.

Authors:  M A Sheridan; T P Mommsen
Journal:  Gen Comp Endocrinol       Date:  1991-03       Impact factor: 2.822

2.  Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.

Authors:  T Wasada; B Howard; R E Dobbs; R H Unger
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

3.  Insulin suppression is associated with hypersomatostatinemia and hyperglucagonemia in glucose-injected rainbow trout.

Authors:  J S Harmon; C D Eilertson; M A Sheridan; E M Plisetskaya
Journal:  Am J Physiol       Date:  1991-09

4.  High plasma free fatty acid levels contribute to the hypersomatostatinemia of insulin deficiency.

Authors:  T Wasada; B Howard; K McCorkle; V Harris; R H Unger
Journal:  Diabetes       Date:  1981-04       Impact factor: 9.461

5.  Differential secretion of glucagon-like and somatostatin-like immunoreactivity from the perfused eel pancreas in response to D-glucose.

Authors:  B W Ince; S T So
Journal:  Gen Comp Endocrinol       Date:  1984-03       Impact factor: 2.822

6.  Difference in glucose dependency of insulin and somatostatin release.

Authors:  P Ronner; A Scarpa
Journal:  Am J Physiol       Date:  1984-06

7.  Secretagogues for pancreatic hormone release in the channel catfish (Ictalurus punctatus).

Authors:  P Ronner; A Scarpa
Journal:  Gen Comp Endocrinol       Date:  1987-03       Impact factor: 2.822

8.  Changes in the fatty acid composition of steelhead trout, Salmo gairdnerii Richardson, associated with parr-smolt transformation.

Authors:  M A Sheridan; W V Allen; T H Kerstetter
Journal:  Comp Biochem Physiol B       Date:  1985

9.  Characterization of coho salmon (Oncorhynchus kisutch) islet somatostatins.

Authors:  E M Plisetskaya; H G Pollock; J B Rouse; J W Hamilton; J R Kimmel; P C Andrews; A Gorbman
Journal:  Gen Comp Endocrinol       Date:  1986-08       Impact factor: 2.822

10.  Differential effects of somatostatin-14 and somatostatin-25 on carbohydrate and lipid metabolism in rainbow trout Oncorhynchus mykiss.

Authors:  C D Eilertson; M A Sheridan
Journal:  Gen Comp Endocrinol       Date:  1993-10       Impact factor: 2.822

View more
  1 in total

1.  Glucose and lipid metabolism in the pancreas of rainbow trout is regulated at the molecular level by nutritional status and carbohydrate intake.

Authors:  Sergio Polakof; Sandrine Skiba-Cassy; Sadasivam Kaushik; Iban Seiliez; Jose Luis Soengas; Stephane Panserat
Journal:  J Comp Physiol B       Date:  2011-12-22       Impact factor: 2.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.